Pharming (PHAR) Free Cash Flow (2019 - 2025)
Pharming's (PHAR) quarterly Free Cash Flow came in at $11.5 million in Q4 2025, up 1239.9% YoY from $854988.9 in Q4 2024, and up 1239.9% on a QoQ basis from -$1.0 million in Q4 2024.
Pharming (PHAR) Free Cash Flow (2019 - 2025) Analysis & Trends
Pharming (PHAR) has 7 years of Free Cash Flow data on file, last reported at $11.5 million in Q4 2025.
- Quarterly Free Cash Flow rose 1239.9% year-over-year to $11.5 million in Q4 2025, while the trailing twelve-month figure through Jun 2026 was $11.5 million (up 25.85% YoY) and the FY2025 annual result came in at $54.0 million, up 2179.34% from the prior year.
- Free Cash Flow advanced to $11.5 million in Q4 2025, from -$1.0 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $13.0 million in Q3 2022 to a low of -$31.4 million in Q2 2023.
- A 5-year average of -$170275.0 and a median of $2.2 million in 2022 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow jumped 1643.52% — and 2023, when it sank 2041.86%.
- Tracing PHAR's Free Cash Flow over 5 years: stood at $46859.3 in 2021, then jumped by 1643.52% to $817000.0 in 2022, then slumped by 2041.86% to -$15.9 million in 2023, then soared by 93.67% to -$1.0 million in 2024, then jumped by 1239.9% to $11.5 million in 2025.
- The last three Free Cash Flow figures came in at $11.5 million (Q4 2025), -$1.0 million (Q4 2024), and $10.1 million (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -389.61 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 437.80 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 477.44 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 292.04 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Pharming | 824.47 Mn | 666.19 Mn | 141.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.46 Mn |
| Dec 31, 2025 | 11.46 Mn |
| Dec 31, 2024 | -1.01 Mn |
| Dec 31, 2024 | -1.01 Mn |
| Sep 30, 2024 | 10.11 Mn |
| Sep 30, 2024 | 10.11 Mn |
| Dec 31, 2023 | -15.87 Mn |
| Dec 31, 2023 | -15.87 Mn |
| Sep 30, 2023 | 3.67 Mn |
| Sep 30, 2023 | 3.67 Mn |
| Jun 30, 2023 | -31.42 Mn |
| Jun 30, 2023 | -31.42 Mn |
| Dec 31, 2022 | 817,000.00 |
| Dec 31, 2022 | 817,000.00 |
| Sep 30, 2022 | 12.96 Mn |
| Sep 30, 2022 | 12.96 Mn |
| Dec 31, 2021 | 46,859.34 |
| Dec 31, 2021 | 46,859.34 |
| Sep 30, 2021 | 7.53 Mn |
| Sep 30, 2021 | 7.53 Mn |